Previous Article | Next Article ![]()
Infection and Immunity, March 2003, p. 1343-1351, Vol. 71, No. 3
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.3.1343-1351.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Biological Sciences, Faculty of Science,1 Tropical Marine Science Institute, National University of Singapore, Singapore 117543, Singapore2
Received 22 July 2002/ Returned for modification 13 November 2002/ Accepted 9 December 2002
|
|
|---|
|
|
|---|
Pathogenesis of E. tarda is multifactorial. Several potential virulence properties have been suggested to contribute to pathogenesis of E. tarda, namely, production of dermatotoxins (44) and hemolysins (21) and the ability to resist phagocyte-mediated (40) and serum-mediated (22, 26) killing and to invade epithelial cells (22, 26). Although both virulent and avirulent E. tarda strains were able to invade cultured cells in vitro, only virulent strains could enter the host, multiply, and spread to various organs, causing mortality (25). In general, very little is known about the genes responsible for virulence and their roles in E. tarda pathogenesis.
Identification of virulence genes is essential for understanding the pathogenesis of bacteria. There are several approaches that can be used for discovering infection-related genes. Some of them are in vivo expression technology (28), signature-tagged mutagenesis (19), random insertion mutagenesis (5), and transposon mutagenesis (4). Here, we have used TnphoA transposon mutagenesis, which allows specific targeting of the secreted, periplasmic, and outer membrane proteins of E. tarda. Attenuated mutants and the corresponding mutant genes were identified through a genome-wide analysis with gourami fish as an infection model. We have also carried out a survey to examine the distribution of these virulence genes in pathogenic and nonpathogenic E. tarda strains and in other pathogenic bacterial genomes. The results of this study assist in furthering our understanding of E. tarda pathogenesis and may be used for the development of diagnostic kits and vaccines for E. tarda and other enteric infections.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and vectors used in this study
|
For the estimation of LD50, three groups of 10 fish each were injected intramuscularly with 0.1 ml of phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4 [pH 7.2]) containing washed bacterial cells adjusted to the required concentrations. LD50s were calculated by the method of Reed and Muench (36).
In vitro characterization of attenuated mutants. PhoA+ fusion mutants were characterized by standard procedures for their ability to grow on TSA and in TSB and phosphate-limiting medium (PLM); production of hemolysin and catalase; and ability to withstand low-pH conditions (pH 5.8) and serum. Briefly, growth of mutants in TSB and on TSA was recorded after 24 h of incubation. Growth under phosphate-limiting conditions was examined by culturing the bacterial cells in a modified defined minimal medium (9) with phosphate salts replaced by 3 µM Na2HPO4 and the pH adjusted to 7.0 with 30 mM HEPES. Hemolysin production was determined by inoculating bacteria on TSA with 5% (vol/vol) heparinized gourami whole blood. A clear zone around a bacterial colony indicated hemolysin production. Catalase production was assayed by adding a drop of H2O2 to a fresh bacterial colony on a TSA plate. Brisk effervescence was associated with the breakdown of H2O2 by endogenous catalase (20). No effervescence was observed for mutants that lacked catalase production. The pH sensitivity of mutants was characterized by estimating their ability to grow in low-pH conditions (16). Overnight bacterial cultures were inoculated into TSB, grown for 3 h to obtain 108 CFU/ml, and inoculated into TSB at pH 5.8 ± 0.1. Subsequently, bacterial growth was monitored over a period of 24 h. Survival of the mutants in serum was determined by incubating the washed bacteria (108 CFU/ml) in 50% (vol/vol) fresh gourami serum for 1 h (48). The serum survival rate was calculated by dividing the viable bacterial population after serum treatment by the initial population. For the serum resistance assay, serum-sensitive (PPD76/87) and serum-resistant (PPD130/91) strains were used as controls. The adhesion assay was carried out in triplicate as described previously (26). All serum data were expressed as means ± standard errors of the means. The data were analyzed by using one-way analysis of variance and a Duncan multiple-range test (SAS software [SAS Institute]). P values of <0.05 were considered significant.
DNA manipulations and Southern hybridization. Bacterial genomic DNA was extracted as described in the manual of the Genome DNA kit (BIO 101). Plasmid DNA was extracted by using QIAprepmini columns (Qiagen). Restriction endonuclease digestion was accomplished by standard methods (37). Southern blotting was performed to confirm the presence of transposon insertions in mutants by using the BluGene nonradioactive nucleic acid detection system (Invitrogen) as described previously (40). Similarly, the presence of virulence genes in different pathogenic and nonpathogenic strains of E. tarda was detected by carrying out Southern hybridization with the respective virulence genes as the probes by the protocol described above.
Cloning of chromosomal segments flanking TnphoA insertions, genome walking, and DNA sequencing. BamHI-digested fragments of mutant genomic DNA flanking the transposon were cloned into the pBluescript SK(+) (Ampr) vector and transformed into Escherichia coli Top10F' competent cells (Clontech). Transformants bearing TnphoA and flanking E. tarda chromosomal sequences were selected by their ability to grow on LB agar containing ampicillin and neomycin. These clones were later sequenced as described below.
To obtain full-length sequences of all of the mutants, a genome walker library of wild type E. tarda PPD130/91digested with EcoRV, PvuII, and StuI was constructed according to the procedure described in the Universal Genome Walker kit (Clontech). PCR amplification was performed with primers that are specific to known upstream nucleotide sequences of mutants and the adapter primer 1. PCR was carried out with Advantage polymerase 2 (Clontech), and the cycling parameters were as follows: 7 cycles of 15 s at 94°C and 3 min at 72°C and 32 cycles of 15 s at 94°C and 3 min at 67°C. The amplified fragments were cloned into the pGEMT Easy vector system (Promega), transformed into E. coli JM109 competent cells, and sequenced with adapter primer 1 and mutant-specific primers.
DNA sequencing was carried out on an ABI PRISM377 automated DNA sequencer by using the ABI PRISMBigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems). Sequence assembly and further editing were carried out with DNASIS DNA analysis software (Hitachi Software). BLASTX and BLASTP sequence homology and protein conserved-domain analyses (CD search) were performed by using the National Center for Biotechnology Information BLAST network service.
In vivo characterization of attenuated mutants. An intramuscular route of administration was used to study the infection kinetics of E. tarda in vivo. Briefly, fish were injected with 1.0 x 105 CFU of E. tarda PPD130/91 (colistin resistant [Colr]) and mutants 19, 135, and 260 (Colr Neor) separately. A control group of fish were injected with 0.1 ml of PBS. Four fish from each group were sampled on days 1, 3, 5, and 7 postinfection. The gall bladder, spleen, kidney, intestine, liver, and heart were aseptically removed. Blood was aseptically collected from the caudal vein. A piece of body muscle from the site of injection, measuring approximately 1 by 1 cm, was also taken. Samples from each treatment were pooled based on organ type and put into sterile sample bags (Whirl-Pak). One milliliter of PBS was added to all of the sample bags, and the contents were homogenized with a Stomacher Lab-Blender (model 80; Seward Medical). The homogenized samples were serially diluted in PBS, plated in triplicate on appropriate media (either TSA with colistin for PPD134/91 or TSA with colistin and neomycin for mutants), and incubated at 25°C for 48 h.
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. Screening for attenutated PhoA+ mutants of E. tarda PPD130/91 with fish as a model
|
|
View this table: [in a new window] |
TABLE 3. Characterization of PhoA+ fusion mutants derived from E. tarda PPD130/91
|
Cloning and sequence analyses of disrupted genes. The genes interrupted by transposon insertions in each of the 15 mutants were cloned and sequenced. Sequence analyses showed that 12 mutants had insertions in different gene loci with significant homology to known genes (Table 4). Mutants 249, 257, and 305 had the transposon inserted in unknown genes. All these mutants were grouped based on the level of attenuation and the gene products encoded by mutated genes, as described below.
|
View this table: [in a new window] |
TABLE 4. Genes disrupted by transposon insertion in PhoA+ fusion mutants of E. tarda
|
Initial characterization of these mutants showed that they formed smaller colonies on TSA than the wild type and were growth deficient in PLM, indicating that these mutants are deficient in the transport of phosphate (Table 3). All three mutants were serum resistant; however, they showed significantly lower replication rates during the 1-h serum treatment than the wild type and were highly attenuated. Daigle and coworkers (10) reported that mutation in pstC gene of an E. coli strain reduced the serum resistance and also the pathogenicity, making it unable to cause septicemia in pigs. Since Pi is an essential element required for most of the biochemical and physiological processes in bacteria, mutation in this operon may affect the uptake of Pi, thereby leading to growth inhibition or the death of the bacteria.
Disruption of genes upstream of phoU may affect the function of phoU due to the polar effect. PhoU is known to act as a repressor of the Pho regulon (35), which includes a PhoB-PhoR two-component regulatory system. Mutation of phoB in V. cholerae has been shown to affect intestinal colonization and therefore pathogenesis (47). Analysis of the pstS mutant of S. enterica serovar Typhimurium indicated that hilA and invasion genes were repressed by the response regulator PhoB in the absence of the PST high-affinity inorganic phosphate uptake system (27). Thus, mutations in PST operon genes may either directly affect the uptake of Pi or indirectly affect the expression of virulence-related genes, leading to attenuation.
Moderately attenuated mutants. (i) Regulatory mutants. Out of eight moderately attenuated mutants, four (mutants 257, 271, 309, and 364) had transposon insertions in different positions of a gene with 45% identity to the secretory system regulatory gene (ssrB) of S. enterica serovar Typhimurium. This gene is known to regulate the type III secretion system (TTSS), a contact-dependent secretory system of Salmonella pathogenicity island 2. Salmonella pathogenicity island 2 plays a central role in systemic infection and in intracellular pathogenesis. The TTSS is required for replication inside macrophages and for systemic infection (18). Mutations in the ssrB gene in S. enterica serovar Typhimurium lead to a loss of virulence (38), as also observed for our mutants. Worley and coworkers (52) have also shown that SsrB activates the global regulon of horizontally acquired genes. Growth of these mutants on TSA and in TSB and PLM was not affected and all were serum resistant, but all had significantly lower replication rates in serum than the wild type (Table 3). None of the ssrB mutants caused severe infection in fish; they all had LD50s well above 100 times that of the wild type. As in the case of Salmonella, SsrB may play an important role in pathogenesis of E. tarda. Further research is required to elucidate whether E. tarda has a pathogenicity island required for the TTSS. Since E. tarda replicates inside phagocytes (40) and is also biochemically similar to Salmonella (23), it might have a similar cluster of genes to facilitate systemic infection.
(ii) Secretion mutants. Three of the mutants (mutants 260, 247, and 309) had insertions in the secreted enzymes GadB, Isor, and KatB, respectively. These enzymes are known to play an important role in providing resistance to bacteria towards phagocyte-mediated killing inside the host. Mutant 260 had single insertion in the gadB gene, which is involved in acid resistance (AR) in E. coli (8). Acidic conditions are common inside phagosomes and the gastrointestinal tract. In order to cause infection, it is necessary for the bacteria to survive in the harsh acidic environment inside phagocytes. Mutant 260 was also sensitive to acidic conditions in vitro (Table 3). E. coli has three different systems for AR, namely, oxidative or glucose-repressed oxidative AR, arginine-dependent AR, and glutamate-dependent AR systems (8). The glutamate-dependent AR system requires the glutamate decarboxylase gene for protection under acidic conditions. The Gad system neutralizes acidity and enhances survival under extreme acid conditions. Transposon insertion in the gadB gene of E. tarda resulted in attenuation of the mutant in vivo and acid sensitivity in vitro, indicating that the mutant was unable to survive and cause infection inside the host.
In order to survive inside the host, microbes have developed complex strategies to avoid or overcome the damaging effects of reactive oxygen species (ROS). We have found an attenuated mutant (mutant 247) that has an insertion in a gene homologous to a putative Fe-S oxidoreductase (isor). Sequence analysis of the isor gene indicated the presence of a CXXXCXXC domain, which is known to bind iron in the 4Fe-4S form (41). Since 4Fe-4S enzymes act as "circuit breakers" halting the production of toxic ROS by temporarily stopping cellular oxidative metabolism, they help the bacteria to survive the microbicidal action of ROS (30). This is the first report that disruption of the isor gene leads to attenuation of pathogenic bacteria.
Mutants 34 and 309 had insertions in the catalase (katB) gene at different positions. Catalase breaks down toxic H2O2 into water and oxygen. H2O2 is an ROS, which can damage cellular constituents such as cell membranes, enzymes, and DNA. H2O2 is produced by phagocytes for microbicidal action. Mutant 34 had a single insertion and was slightly attenuated, having an LD50 1.5 log units higher than that of the wild type (29), while mutant 309 had double transposon insertions, one in the katB gene and another in the ssrB gene, and had an LD50 2 to 3 log units higher than that of the wild type. Neither of these two mutants produced effervescence upon contact with H2O2, indicating that they had impaired catalase production (Table 3). Catalase has been shown to be a virulence factor in bacterial pathogens such as Haemophilus influenzae (6) and Mycobacterium bovis (50). Although there were some variations in the two catalase mutants (mutants 34 and 309) of E. tarda, both of them were attenuated in fish, indicating the role of these mutations in virulence.
(iii) Outer membrane protein mutant. Outer membrane proteins (Omps) are known to play a protective role for pathogenic bacteria by causing resistance to serum- and complement-mediated killing. DsrA, an outer membrane protein of Haemophilus ducreyi, conferred resistance to serum-mediated killing (12). Mutant 271 had an insertion in a gene having 75% identity to ompS2 of S. enterica serovar Typhimurium and was also slightly serum sensitive (Table 3). Serum resistance has been shown to be critical for survival and establishment of disease in the host for several bacteria. The disruption of the omp gene might have led to the serum sensitivity, thereby making the mutant avirulent. Mutant 271 also had another insertion in the ssrB gene. Further studies with isogenic mutations in these genes would help in understanding their individual role in the pathogenesis of E. tarda.
(iv) Other virulence gene mutants. Mutant 257 had insertions in a gene having homology to a hypothetical protein of Y. enterocolitica (orf20) and the citrate lyase ligase gene (citC) of E. coli. orf20 is one of several genes present in the high-pathogenicity island of Y. enterocolitica (34). The high-pathogenicity island is known to mediate biosynthesis and uptake of the siderophore yersinibactin and to contribute to the mouse-lethal phenotype. The citrate lyase ligase gene (citC) is one of the five genes in the citrate lyase operon. This operon helps in cleaving citrate to oxaloacetate and acetate. Since mutant 257 had triple insertions, association of citC with virulence of bacteria could be validated only by testing for attenuation of isogenic mutants.
Two of the mutants (249 and 305) had single transposon insertions at different positions in a novel gene (orfA). This gene may encode for an important secreted or membrane protein, since these mutants were PhoA+. Further studies are required to elucidate the function of this gene.
Slightly attenuated mutants. (i) Adherence mutants. Fimbriae are known to help in adhesion of bacteria to host cells (11). Mutant 19 had an insertion in the fimA gene, the first gene in fimABCDE operon. Compared to the wild-type E. tarda PPD130/91, the adherence to epithelioma papillosum of carp cells by mutant 19 was 5 times lower (adhesion to epithelioma papillosum of carp cells by PPD130/91 and mutant 19 was 3.9 ± 0.7 and 0.8 ± 0.2, respectively [n = 3]). Adherence is the primary step for invading the host and causing infection. Hence, any mutation in genes involved in attachment would affect the infective ability of the bacteria, which would have led to attenuation of this mutant. Vander Velden and coworkers (46) also have shown that multiple fimbrial adhesins are required for full virulence of S. enterica serovar Typhimurium in mice. They reported that mutations in fimbrial operons reduced the virulence of the bacteria.
(ii) Other mutants. Mutant 337 had a transposon insertion in a gene having homology to mukF (kicB) of E. coli (Table 4). In E. coli, a null mutation of the mukF gene led to temperature-dependent colony formation, anucleate cell production, chromosome cutting by septum closure, and hypersensitivity to novobiocin (31). MukF is present in a complex of MukF (KicB)-MukE (KicA) and MukB proteins. Feng and coworkers (14) suggested that the kicB (mukF) gene encodes a killing factor which kills cells and that the kicA gene codes for a protein that suppresses the killing function of kicB gene product. They also showed that a kicA null mutant is nonviable but that kicB mutants are able to grow. In the present study we found that a mutation in mukF gene led to a slight attenuation of E. tarda, indicating its possible role in affecting virulence. Mutants 2A, with an insertion in astA, and 34, with an insertion in katB, were deficient in siderophore and catalase production, respectively, rendering them slightly attenuated, as discussed elsewhere (29).
In vivo infection kinetics of attenuated mutants. Infection kinetics experiments were carried out to investigate the ability of the mutants to proliferate and cause infection in vivo. This measures the potential of the bacteria to invade, survive, colonize, and replicate in various organs of the host. An intramuscular infection model was used to simulate infection by physical injury under normal conditions. Hence, one representative mutant from each of the three groups described above and the wild type were injected separately into fish, and the infection kinetics was studied over a period of 7 days. Fish injected with PPD130/91 showed high numbers of bacteria in all of the different organs, followed by mutants 19 (slightly attenuated), 260 (moderately attenuated), and 135 (highly attenuated) (Fig. 1). By day 1, wild-type PPD130/91 could survive, colonize, and proliferate to reach very high numbers in all of the organs sampled, thereby causing mortality of fish within 3 to 5 days (Fig. 1A). In the case of mutant 19, the bacterial numbers were slightly lower than for the wild type but higher than for mutants 260 and 135 (Fig. 1B). Mutant 19 could survive and colonize in the muscle and reached levels comparable to that of wild type, but it still could not cause fish mortality. The bacterial numbers of this mutant were reduced to lower levels in all of the organs except muscle by 3 days postinfection. For both mutants 260 and 135, bacteria could not survive and colonize in all of the organs and were possibly killed by the host defense mechanisms (Fig. 1C and D). None of the fish succumbed to infection when injected with mutants 260 and 135. Fish injected with the wild type and mutant 19 showed hemorrhages around the site of injection, which persisted and progressed in the case of the wild type but decreased and healed in the fish injected with mutant 19. For the fish injected with mutants 260 and 135, no hemorrhages were observed at any time during the experiment. This clearly indicated that the wild type and mutant 19 could survive and colonize in muscle and cause an extensive inflammatory response compared to mutants 260 and 135. Infection kinetics experiments also demonstrated the inability of mutants with defective fimA, gadB, and pstC genes to establish fatal infection in fish.
![]() View larger version (27K): [in a new window] |
FIG. 1. Infection kinetics of E. tarda strains in blue gourami. Fish were injected with 1.0 x 105 CFU of PPD130/91 (A), mutant 19 (B), mutant 260 (C), and mutant 135 (D). Four fish each were sampled per datum point, and the mean numbers of E. tarda per sample in triplicates are shown. For PPD130/91, sampling was done until day 5, when all of the fish died due to severe infection. Fish from the other groups were sampled until day 7. Blood (), body muscle ( ), liver ( ), kidney ( ), gall bladder (- - - -), spleen ( ), heart (· · - - · ·), and intestine ( ) were dissected and homogenized, and bacterial enumeration was done by plating onto TSA supplemented with appropriate antibiotics.
|
|
View this table: [in a new window] |
TABLE 5. Distribution of virulence genes in various virulent and avirulent strains of E. tarda
|
Biocomputational analysis was carried out to determine the distribution of the these genes in other pathogenic bacteria. Most of the 14 virulence genes required for E. tarda infection have related sequences in other common human pathogens, such as enterohemorrhagic E. coli, S. enterica serovar Typhimurium, V. cholerae, and others (Table 6). Genes such as fimA, pstS, and ssrB play an important role in pathogenesis of S. enterica serovar Typhimurium (18, 27, 51). Some other genes are known to contribute to virulence in other bacterial pathogens whose complete genomes are not available. This is not unexpected given the genetic relatedness of some of these bacteria and their similarity as enteric and systemic pathogens. These common virulence genes will be useful in determining how pathogenic bacteria interact with the host and cause systemic infections. They may also form the basis for the design of novel therapeutics and common antigens in vaccine development to protect hosts against systemic diseases.
|
View this table: [in a new window] |
TABLE 6. Distribution of virulence genes in other pathogenic bacteria and their E values
|
For any bacterium to cause an infection, it has to adhere to (fimA) and invade the host. Once inside the host, bacteria have to survive and overcome defensive barriers such as serum and phagocyte-mediated killing. These are the major host defenses against septicemia infection. Hence, it is not surprising to find the genes (gadB, isor, katB, ompS2, and ssrB) which neutralize these effects in the present study. Later, during infections, bacteria need to acquire nutrients to proliferate within the host. pst genes and astA help in acquiring nutrients such as phosphate and iron within the host. Some regulatory elements (phoU and ssrB) are also probably required to enable E. tarda to switch on the necessary virulence genes to establish itself inside fish, causing severe systemic infection and eventually death. Here we have made an attempt to connect all of the genes and postulate their combined roles in the systemic infection.
This study has allowed us to identify E. tarda genes required to cause infection in fish. Further study of these genes will improve our understanding of the mechanisms of E. tarda pathogenesis. The genes that were present only in pathogenic bacteria can now be used for developing diagnostic reagents to identify the pathogenic E. tarda strains. Some of the genes identified here may also be future vaccine candidates.
We are grateful to John Grizzle (Auburn University), H. Wakabayashi (University of Tokyo), and T. Ngiam and H. Loh (Agri-food and Veterinary Authority of Singapore) for providing us with E. tarda isolates from the United States, Japan, and Singapore, respectively. We also acknowledge J. A. Mathew, who carried out the mutagenesis of E. tarda PPD130/91. We thank Peter Howard and Shashikant Joshi for their constructive criticism.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»